The study is the first ever to link chlorhexidine exposure with colistin resistance.
Researchers tested strains of K. pneumoniae typically found in healthcare and exposed them to increasing concentrations of chlorhexidine. While some strains died from the exposure, others survived and some gained resistance to colistin.
They also discovered gene mutations in some of the surviving strains that conferred resistance to both colistin and chlorhexidine.
“Chlorhexidine is a critical part of current infection control practices, and the development of increased resistance to this compound has potential implications for our ability to prevent infections during routine and emergency surgery, and during admission to hospitals,” said J. Mark Sutton, PhD, the study’s co-author.
“This might mean that we need to rethink how and where some types of critical disinfectants or antiseptics are used in the clinic,” he said.
More articles on antibiotic resistance:
Emerging deadly yeast infection sees biggest outbreak so far in London
CDC adds $14M to fight against antibiotic resistance
Researchers develop new device to test for antibiotic-resistant bacteria
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
